CLINICAL IMMUNOLOGY
Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer
Submission date: 2016-03-06
Final revision date: 2016-06-02
Acceptance date: 2016-06-06
Publication date: 2017-05-08
Cent Eur J Immunol 2017;42(1):73-77
KEYWORDS
ABSTRACT
Cancer is the second leading cause of death and gastric cancer is the fourth most common cancer type worldwide. Investigation of autoantibodies in cancer patients has been a popular research area in recent years. The aim of the current study was to investigate carbonic anhydrase I and II (CA I and II) autoantibodies in the plasma of subjects with gastric cancer based on the information and considerations of autoimmune relation of gastric cancer. Anti-CA I and II antibody levels were investigated by ELISA in plasma samples of fifty two patients with gastric cancer and thirty five healthy peers. Anti-CA I and II antibody titers of the gastric cancer group were significantly higher compared with the control group (p = 0.004, p = 0.0001, respectively). Plasma anti-CA I levels of the metastatic group were lower than the non-metastatic group and this difference was found statistically significant (p < 0.05), but there was no statistical difference between plasma anti-CA II levels of the groups. CA I and II autoantibody titers in patients with gastric cancer were found higher compared to healthy subjects and the results suggest that these autoantibodies may be involved in the pathogenesis of gastric cancer.
REFERENCES (32)
1.
Abu-Shakra M, Buskila D, Ehrenfeld M, et al. (2001): Cancer and autoimmunity: Autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 60: 433-441.
2.
Ortona E, Pierdominici M, Berstein L (2014): Autoantibodies to estrogen receptors and their involvement in autoimmune diseases and cancer. J Steroid Biochem Mol Biol 144: 260-267.
3.
Chapman CJ, Murray A, McElveen JE, et al. (2008): Autoantibodies in lung cancer: Possibilities for early detection and subsequent cure. Thorax 63: 228-233.
4.
Zhong L, Ge K, Zu JC, et al. (2008): Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res 10: R40.
5.
Lowe FJ, Shen W, Zu J, et al. (2014): A novel autoantibody test for the detection of pre-neoplastic lung lesions. Mol Cancer 13: 78.
6.
Wei ZW, Xia GK, Wu Y, et al. (2015): CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Cancer Lett 359: 335-343.
7.
Siegel RL, Miller KD, Jemal A (2015): Cancer statistics, 2015. CA Cancer J Clin 65: 5-29.
8.
Sipponen P (2002): Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol 37: 39-44.
9.
Heneghan MA, McCarthy CF, Janulaityte D, et al. (2001): Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity. Infect Immun 69: 4774-4781.
10.
Supuran CT (2008): Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7: 168-181.
11.
Mentese A, Guven S, Sumer A, et al. (2013): Serum anti-carbonic anhydrase I and II antibodies and polycystic ovary syndrome. Turk J Biochem 38: 43-48.
12.
Kivela AJ, Kivela J, Saarnio J, et al. (2005): Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours. World J Gastroenterol 11: 155-163.
13.
Adamus G (2009): Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev 8: 410-414.
14.
Alver A, Senturk A, Cakirbay H, et al. (2011): Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis. Clin Biochem 44: 1385-1389.
15.
Edge SB, Byrd DR, Compton CC, et al. editors. AJCC cancer staging manual (7th ed). Springer, New York 2010.
16.
Kino-Ohsaki J, Nishimori I, Morita M, et al. (1996): Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjögren’s syndrome. Gastroenterology 110: 1579-1586.
17.
Fedele C, Carvalho S, Riccio G, et al. (2014): Effects of a human compact anti-ErbB2 antibody on gastric cancer. Gastric Cancer 17: 107-115.
18.
Werner S, Chen H, Tao S, et al. (2015): Systematic review: Serum autoantibodies in the early detection of gastric cancer. Int J Cancer 136: 2243-2252.
19.
Zaenker P, Ziman MR (2013): Serologic autoantibodies as diagnostic cancer biomarkers-A review. Cancer Epidemiol Biomarkers Prev 22: 2161-2181.
20.
Sly WS, Hu PY (1995): Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64: 375-401.
21.
Boztas M, Cetinkaya Y, Topal M, et al. (2015): Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties. J Med Chem 58: 640-650.
22.
Parkkila S, Lasota J, Fletcher JA, et al. (2010): Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors. Mod Pathol 23: 743-750.
23.
Pedersen JW, Wandall HH (2011): Autoantibodies as biomarkers in cancer. Lab Medicine 42: 623-628.
24.
Iuchi Y, Okada F, Onuma K, et al. (2007): Elevated oxidative stress in erythrocytes due to SOD1 deficiency causes anemia and triggers autoantibody production. Biochem J 402: 219-227.
25.
Uchida K, Hasui Y, Osawa T (1997): Covalent attachment of 4-hydroxy-2-nonenal to erythrocyte proteins. J Biochem 122: 1246-1251.
26.
Bergman MP, D’Elios MM (2010): Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma. J Biomed Biotechnol; Article ID: 104918, DOI: 10.1155/2010/104918.
27.
Buckley MJ, O’Morain CA (1998): Helicobacter biology-discovery. Br Med Bull 54: 7-16.
28.
Zhang S, Lee DS, Morrissey R, et al. (2014): Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. Cancer Lett 355: 106-112.
29.
Kountouras J, Zavos C, Chatzopoulos D (2005): Autoimmune pancreatitis, Helicobacter pylori infection, and apoptosis: a proposed relationship. Pancreas 30: 192-193.
30.
Bhatia M (2005): Molecular mimicry in autoimmune pancreatitis: An interesting idea. J Cell Mol Med 9: 745.
31.
Woodard KM, Chapman CJ (2008): Lung cancer-can autoantibodies provide an aid to diagnosis? Expert Opin Med Diagn 2: 911-923.
32.
Alver A, Mentese A, Mentese U, et al. (2014): Anti-carbonic anhydrase II antibodies in end-stage renal disease patients. Med Princ Pract 23: 331-335.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
